利索-全球专利检索

  1. 登录
  2. 注册
发明公开
CN104013625A 一种治疗疣疾病的组合药物 无效 - 撤回

一种治疗疣疾病的组合药物
摘要：
本发明公开了一种治疗疣疾病的组合药物，其特征在于，包括活性组分A和活性组分B，活性组分A为磷酸氯喹、硫酸氯喹、硫酸羟氯喹中的一种，活性组分B为利多卡因、普鲁卡因、布比卡因中的一种；其中：活性组分A占药物总重量的5%-25%；当活性组分B为利多卡因时，活性组分B占药物总重量比例的0.5%-2%；当活性组分B为普鲁卡因时，活性组分B占药物总重量比例的0.8%-2%；当活性组分B为布比卡因时，活性组分B占药物总重量比例的0.8%-2%。本发明的组合药物具有药物来源广泛，经济、廉价、外用方便、治愈率高、未见复发，未有明显的毒副作用等特点，能清除HPV病毒、适用于各种因HPV感染引起的疣的治疗。
摘要（英）：

The invention discloses a combined drug for treating verruca diseases. The combined drug is characterized by comprising an active component A and an active component B. The active component A is one of chloroquine phosphate, chloroquine sulfate and hydroxychloroquine sulfate; and the active component B is one of lidocaine, procaine and bupivacaine. The active component A accounts for 5%-25% of a total weight of the drug; the active component B accounts for 0.5%-2% of the total weight of the drug when the active component B is lidocaine; the active component B accounts for 0.8%-2% of the total weight of the drug when the active component B is procaine; and the active component B accounts for 0.8%-2% of the total weight of the drug when the active component B is bupivacaine. The combined drug provided by the invention is wide in raw material resource, is economic and cheap, is convenient for external use, has a high curative rate, has no recurrence and no obvious toxic and side effect, can clear HPV viruses, and is suitable for treating verruca caused by various HPV infections.

0/0